Kazia Therapeutics
Hornsby
About Kazia Therapeutics
Kazia Therapeutics is an oncology focused biotechnology company, developing innovative anti-cancer drugs. Kazia Therapeutics collaborates with leading scientists, clinicians and investors around the world.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $45.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Dec 2025)
- Ticker: nasdaq:KZIA
- Website: kaziatherapeutics.com
- Phone: +61 2 9472 4100
Industries & Categories
Biotechnology, Clinical Trials, Commercial, Innovation Management, Oncology
Social Profiles
Canonical: https://fsome.com/organization/kazia-therapeutics-129752 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.